IOL Chemicals receives COPP certificate for ibuprofen and lamotrigine
The receipt of certificates of pharmaceuticals products (COPP) from Punjab's Food & Drugs Administration (FDA) will facilitate IOLCP to broaden its presence in export market
 "IOL Chemicals receives COPP certificate for ibuprofen and lamotrigine")
IOL Chemicals & Pharmaceuticals Ltd (IOLCP) has received certificates of pharmaceuticals products (COPP) for manufacturing facilities of ibuprofen and lamotrigine in its existing multi-purpose plant from Food & Drugs Administration, Punjab. This will facilitate IOLCP to broaden its presence in export market.
While ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of various types of pains, lamotrigine is an anti-convulsant drug used for treating epileptic seizures.
IOL Chemicals already has US FDA and European Directorate for the Quality of Medicines & Healthcare (EDQM) approved ibuprofen manufacturing facilities.
While ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of various types of pains, lamotrigine is an anti-convulsant drug used for treating epileptic seizures.
IOL Chemicals already has US FDA and European Directorate for the Quality of Medicines & Healthcare (EDQM) approved ibuprofen manufacturing facilities.